Cultures were maintained

for 3 days at 37°C in a 5% CO2 atmosphere. B cell purity, apoptosis, proliferation and surface marker expression were analysed by flow cytometry using an Epics FC500 flow cytometer and the CXP software (Beckman Coulter). Cell purity was assessed using the following monoclonal antibody combinations: anti-CD45 fluorescein isothiocyanate (FITC), anti-CD19 phycoerythrin cyanin 5 (PCy5) (both from Coulter Immunotech) and anti-CD3 phycoerythrin (PE) (Becton Dickinson, Franklin Lakes, NJ, USA) for purified B cells and anti-CD19 PCy7 plus anti-CD27 PCy5 (both from Coulter Immunotech) for sorted CD27– and CD27+ B cells. Purity was always superior to 95%. Annexin V and propidium iodide staining protocol (Becton Dickinson) was performed to evaluate apoptosis of CSFE-free purified (Fig. 1a) and sorted CD27– and CD27+ B cells (Fig. 1b,c),

following see more the manufacturer’s instructions. Briefly, 1 × 105 cultured CFSE-free cells were harvested, stained with anti-CD19 PCy7 and anti-CD27 PCy5, washed with cold phosphate-buffered saline (PBS), resuspended in 100 μl binding buffer and stained with 5 μl of a 1·2 μg/ml solution of annexin V-FITC and 5 μl of a 50 μg/ml solution of propidium iodide. Cells were incubated for 15 min at RT (25°C) in the dark, resuspended Selleck Ceritinib in 400 μl of binding buffer and analysed. Propidium iodide positivity was used to exclude necrotic CD19+ cells and percentage of apoptotic cells (annexin V-FITC-positive) was calculated from the resulting population. Rescue from apoptosis was expressed as [(% baseline apoptosis − % post-stimulation apoptosis)/% baseline apoptosis] × 100, to indicate the decrease in apoptosis induced by each stimulus related to baseline apoptosis. A CFSE dilution protocol was used to evaluate the proliferation of CFSE-labelled cultured purified B cells. Proliferation index was calculated on CD19+CD27– or CD19+CD27+ stained B cells attending to the number of divisions and the percentages

of cells in each round of division, as described previously by Quah et al. [30]. TRAIL expression Teicoplanin was evaluated in whole blood samples stained with anti-CD19 energy-coupled dye (ECD), anti-CD27 PCy7 (both from Coulter Immunotech) and anti-TRAIL-PE (Becton Dickinson)-conjugated monoclonal antibodies. TRAIL median fluorescence intensity (MFI) was measured in previously gated CD19+CD27– and CD19+CD27+ B cells. Statistical analysis was performed using GraphPad Prism version 4·0 software (San Diego, CA, USA). Data are expressed as median and 25th and 75th percentiles. The Mann–Whitney U-test was used to compare differences between B cells subpopulations. The Kruskal–Wallis test was used to compare differences between CVID patients groups and controls.